Pay in 4 interest-free payments of $6.60 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
By Formulation: Injectable Pens Dominate While Oral Tablets Target Injection-Averse Cohorts Injectable pens accounted for 59.73% of 2025 revenue and are forecast to grow at a 16.87% CAGR, as once-weekly dosing sustains 72% 12-month adherence
In 2021, it gained FDA approval for chronic weight management under the name Wegovy, representing a significant advancement in obesity treatment options
Continued portion control with five to six small meals daily
Because gastric emptying is slowed, food lingers longer in the stomach, creating that heavy, unsettled feeling
A history of anxiety does not automatically disqualify you from GLP-1 therapy, but it requires closer monitoring and slower dose escalation
